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Abstract 
Purpose: In December 2019, a new coronavirus (SARS-CoV-2) was identified as being responsible for the pulmonary 
infection called COVID-19. On 21 February 2020, the first autochthonous case of COVID-19 was detected in Italy. 
Our goal is to report the most common chest computed tomography (CT) findings identified in 64 patients, in the 
initial phase of COVID-19.
Methods: Sixty-four chest high-resolution computed tomography (HRCT) examinations performed at the Radiology 
Unit of the Hospital of Cremona, from 22 to 29 February 2020, of 64 patients during first week of hospitalization for 
COVID-19 were retrospectively evaluated. All cases were confirmed by real-time RT-PCR for SARS-CoV-2. Image 
analysis was independently conducted by 2 radiologists with 10 years and 1 year of experience in chest imaging.  
The inter-observer agreement was obtained by applying a Cohen’s κ test.
Results: The average age of patients was 67.1 years (± 12.2); men 42 (66%). HRCT was performed on the 5th (± 1.5) 
day of hospitalization. More frequently, the initial CT changes of the lung show more or less extensive areas of 
ground-glass, as single pattern or with parenchymal consolidations. Coronavirus lung involvement appears very 
frequently multi-lobar, bilateral, and it concerns both subpleural and central regions. An excellent agreement  
(κ: 0.88-1, CI: 0.79-1.01, p < 0.05) concerning CT findings between the 2 operators was reached.
Conclusions: Our data suggest that detection of the most frequent pulmonary CT-scan changes, in the early stages of 
COVID-19, can be performed, with excellent agreement, among readers with different experience, and consequently 
attribute their exact diagnostic value, in an appropriate clinical and environmental exposure setting.
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Introduction
In December 2019, a new coronavirus (SARS-CoV-2) was 
identified as being responsible for the pulmonary infec-
tion called COVID-19 (coronavirus disease 2019) [1-5]. 
On 21 February 2020, the first autochthonous case of coro-
navirus infection (COVID-19) was detected in Italy in 
a 38-year-old man who arrived in an emergency room in 
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the Lombardy region in the Hospital of Codogno (30 km 
away from Cremona) with fever and respiratory symptoms. 
Approximately 7 days after the first infection, the 
Hospital of Cremona (Lombardy) was treating about 
109 coronavirus patients (2019-nCoV). Symptomatic pa-
tients (COVID-19) in almost all cases had non-productive 
cough, fever, and respiratory failure. In the first week of 
hospitalization, about 65 patients underwent high-reso-
lution computed tomography (HRCT) of the chest. Chest 
computed tomography (CT) investigations of the chest 
were necessary, especially in cases of inconsistency be-
tween the patient’s clinical data and the findings of the 
corresponding chest X-rays. 
Our aim is to present the most common findings 
identified in 64 HRCTs of the chest related to 64 different 
patients with COVID-19, in the initial stage of infection.
Material and methods
Our institutional review board (IRB) waived written in-
formed consent for this retrospective study, not recogniz-
ing any potential risks of violation of patient confidentiality. 
Sixty-four chest HRCT examinations, performed at 
the Radiology Unit of the tertiary Hospital of Cremona, 
from 22 February to 29 February 2020, in 64 patients dur-
ing the first week of hospitalization for COVID-19, were 
retrospectively evaluated. All cases were confirmed by 
real-time RT-PCR for SARS-CoV-2. The analysis of the 
chest CT exams was independently conducted by 2 radio-
logists with 10 years (Reader A) and 1 year (Reader B) of 
experience in chest imaging. 
A standard nomenclature defined by the Fleischner 
Society glossary [6] was used for CT findings: crazy pav-
ing, ground glass, consolidation, and perilobular pattern. 
A semi-quantitative scoring system was used to quanti-
tatively estimate the pulmonary involvement. Lung in-
volvement was classified mild, moderate, and severe. Mild 
involvement was when the sum of the parenchymal abnor-
malities in both lungs was equal to or less than the volume 
of the respective upper segment of the Right Upper Lobe 
(RUL). Moderate involvement was when the sum of the 
parenchymal abnormalities in both lungs was greater than 
the volume of the respective upper segment of the RUL, 
but equal to or less than the overall RUL volume. Severe in-
volvement was if the sum of the parenchymal abnormalities 
in both lungs was greater than the RUL volume.
The distribution of the findings was recorded as sub-
pleural (involving the peripheral lung zones, including 
perifissural zones, less than 1 cm from pleural surface), 
central (if more than 1 cm from the pleural surface, in-
cluding perifissural zones), or combined (when subpleural 
and central lesions coexisted). The number of lung lobes 
involved was recorded: right upper lobe (RUL), left up-
per lobe (LUL), right middle lobe (RML), right lower lobe 
(RLL), and left lower lobe (LLL), and we considered lingu-
la as different lobes for better classification. The presence 
or absence of pleural effusion was also recorded.
The inter-observer agreement was obtained by apply-
ing a Cohen’s κ test (0: no concordance, 1: maximum con-
cordance). The results are reported with 95% confidence 
interval, and a p-value <0.05 was considered statistically 
significant. Data were analysed with Statistical Analysis 
System (IBM SPSS Statistics v. 23). 
Results
The average age of patients undergoing HRCT of the 
chest was 67 ± 12 years (range: 32-85 years). Men totalled 
42 (66%) and women 22 (34%). On average the CT scan 
examination was performed on the 5th ± 1.5 day of hospi-
talization (Table 1). 
Table 1. Demographic characteristics 
Parameter
Number of patients 64
Sex M = 42 (66%), F = 22 (34%)
Age (years) 67.1 (± 12.2 SD; range: 32-85)
Days* 5 (±1.5 SD)
*Average interval of days between hospitalization and execution of the first chest computed 
tomography scan
Figure 1. Chest high-resolution computed tomography in a 57-year-old man, unknown comorbidi-
ties. Fever and non-productive cough. Leukocytosis. Hypoxaemic and hypocapnic respiratory failure. 
Suspected contact with red zone subjects. NCOV-19 positive swab. A and B) In all pulmonary lobes ex-
tensive areas of increased attenuation are evident. In particular, the prevailing pattern is represented 
by ground glass opacities, with a tendency towards consolidation in the posterior regions. C) The alte-
rations present a predominantly subpleural distribution and appear more evident at the lower lobes
A B C
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Data relating to Reader A
Ground glass opacities were identified in 63 patients 
(98.4%), parenchymal consolidations in 38 patients (59.3%), 
perilobular pattern in 17 patients (26.5%), and crazy pav-
ing pattern in 4 patients (6.2%). The most frequent asso-
ciation between the different patterns was the combination 
of ground glass and consolidation in 37 patients (57.8%) 
(Figures 1 and 2). On average 5.3 lobes per patient were in-
volved. Central distribution of the alterations was identified 
in 50 patients (78.1%), subpleural distribution in 58 patients 
(90.6%), and the combination of central and subpleural 
distribution in 44 patients (68.7%) (Figure 3). The exten-
sion was judged mild in 15 patients (23.4%), moderate in 
22 patients (34.3%), and severe in 27 patients (42.1%). Pleu-
ral effusion was identified in 7 patients. 
Data relating to Reader B
Ground glass opacities were identified in 62 patients 
(96.8%), parenchymal consolidations in 39 patients 
(60.9%), perilobular pattern in 12 patients (18.7%), and 
crazy paving pattern in 6 patients (9.3%). The most fre-
quent association between the different patterns was 
the combination of ground glass and consolidation in 
37 patients (57.8%). On average 5.4 lobes per patient were 
involved. Central distribution of the alterations was iden-
tified in 45 patients (70.3%), subpleural distribution in 
62 patients (96.8%), and the combination of central and 
subpleural distribution in 43 patients (67.1%). The ex-
tent was judged mild in 10 patients (15.6%), moderate in 
20 patients (31.2%), and severe in 34 patients (53.1%). 
Pleural effusion was identified in 7 patients (Table 2). 
An excellent agreement (Cohen’s κ: 0.88-1, CI: 0.79-1.01, 
p < 0.05) was found between the 2 operators concerning 
CT findings (Table 3). 
Discussion
Numerous experiences from endemic areas of China sug-
gest that chest CT scan is a vital tool in the diagnostic al-
gorithm for patients with suspected COVID-19 infection 
Figure 2. Chest high-resolution computed tomography in a 43-year-old man, unknown comorbidities. Fever and non-productive cough. Leukopaenia. 
Hypoxaemic and hypocapnic respiratory failure. Contact with red zone subjects. NCOV-19 positive swab. Extensive ground glass opacity in the left lower 
lobe, with consolidation in the context (mixed lesion). Smaller lesion with similar attenuation features in the right lower lobe. Small ground glass areas in 
both upper lobes. The alterations have a subpleural distribution
Figure 3. Chest high-resolution computed tomography in a 45-year-old man, unknown comorbidities. 
Fever and non-productive cough. Leukocytosis. Hypoxaemic and hypocapnic respiratory failure. Contact 
with red zone subjects. NCOV-19 positive swab. A and B) In all pulmonary lobes there are evident 
multiple areas of ground glass attenuation. In the subpleural regions of the apical segments of both 
lower lobes, a perilobular distribution of ground-glass lesions is observed. C) The ground glass areas 
have both central and subpleural distribution
A B C
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[4,5,7-10]. In particular, it is useful as a preliminary study 
in the evaluation of pulmonary abnormalities, in defin-
ing the extent of the disease, and in assessing the subse-
quent course of the disease. Non-contrast high-resolution 
computed tomography is the method of choice in patients 
with suspected or confirmed COVID-19 [11]. Integrated 
imaging for COVID-19 is the best key to reaching a con-
fident diagnosis [12].
In our Radiology Department, during the first week of 
hospitalization, 64 symptomatic patients with COVID-19 
infection underwent HRCT of the chest. Fifty-eight pa-
tients out of 64 had simultaneous fever, cough, and respira-
tory failure. Chest CT-scan investigations were necessary, 
especially in cases of inconsistency between the patient’s 
clinical data and the findings of the corresponding chest 
X-rays. These data were due to the low sensitivity of the 
chest X-ray in the detection of interstitial alterations (e.g. 
ground-glass), and the rapid progression of pulmonary 
parenchymal findings.
The incidence of COVID-19 appears to be more fre-
quent in the male population (Table 1), as described by 
Sun et al. [13]. Moreover, our data allow us to state that 
coronavirus lung involvement (COVID-19) is very fre-
quently multi-lobar, bilateral, and affects both the sub-
pleural and central regions of the lungs. Subpleural in-
volvement is moderately more frequent than central 
involvement (Table 2).
More frequently, the initial CT findings of the lung 
are represented by more or less extensive areas of ground 
glass as a single pattern or in association with parenchy-
mal consolidations. Infrequent patterns are represented by 
crazy paving and peri-lobular changes. Such patterns, in 
our experience, are always in association with ground glass 
areas and/or consolidations, and never dominant pattern. 
The parenchymal consolidations and ground-glass areas 
may also show areas of sparing lobular morphology, and 
their zonal arrangement does not respect a sub-segmental, 
segmental, or lobar anatomical distribution.  
With regard to the nature of the highlighted lesions, we 
interpret the findings as diffuse alveolar damage (DAD) or 
acute fibrinous and organizing pneumonia (AFOP) altera-
tions. We prefer these terms in the radiological description, 
rather than ARDS, considering ARDS as the clinical syn-
drome associated with such alterations [14]. 
We can add that no alterations such as centrilobular 
nodules, tree in bud patterns, or alterations of the periphe-
ral airways, typical data of inflammatory involvement of 
small airways, of bronchiolitis and/or parenchymal type 
(e.g. acinar), were found. There was infrequent evidence of 
pleural effusion, and when present, it was commonly bilat-
eral and mild.
A further element of interest is the degree of pulmo-
nary involvement in the early stages of the disease. More 
specifically, we have identified a semi-quantitative criterion 
of lung disease extension, in addition to clinical signs and 
laboratory parameters, for the risk stratification of patients 
with COVID-19. In particular, in the management of our 
patients, it was important to know that in the initial phase 
of the disease about 23% of the subjects had mild pulmo-
nary involvement and about 42% of our patients had se-
vere pulmonary involvement (Table 2). We need a further 
period of observation and further investigation to under-
stand whether the degree of initial extension of the disease 
can be considered a prognostic factor in the subsequent 
clinical course of the disease.
It is interesting to observe that for all the data collected 
by the two different operators, with different degrees of 
experience in thoracic radiology (10 years and 1 year, re-
spectively), the inter-observer concordance between the 
various CT alterations was always in an optimal range (k 
0.8-1). In our opinion, that shows that the main identified 
CT characteristics of COVID 19 can be easily diagnosed by 
experienced radiologists and by less experienced radiolo-
Table 3. Inter-observer agreement between first and second operator. Kap-
pa – Cohen’s k, CI – confidence intervals. P – statistical significance < 0.05





Crazy paving 0.99 0.97-1.01
Distribution 0.88 0.82-0.94
Lung involvement 0.88 0.82-0.94
Pleural effusion 1 1
Table 2. High-resolution computed tomography (HRCT) lung findings
HRCT findings Reader A Reader B 
Pattern
Ground-glass 63/64 (98.4%) 62/64 (96.8%)
Consolidation 38/64 (59.4%) 39/64 (60.9%)
Perilobular 17/64 (26.6%) 12/64 (18.7%)
Crazy paving 4/64 (6.2%) 6/64 (9.4%)
Ground-glass and consolidation 37/64 (57.8%) 37/64 (57.8%)
Distribution
Central 50/64 (78.1%) 45/64 (70.3%)
Subpleural 58/64 (90.6%) 62/64 (96.8%)
Combined 44/64 (68.7%) 43/64 (67.1%)
Localization
Number of involved lobes 5,3/6 (88.3%) 5,4/6 (90.0%)
Lung involvement
Mild 15/64 (23.4%) 10/64 (15.6%)
Moderate 22/64 (34.3%) 20/64 (31.1%)
Severe 27/64 (42.2%) 34/64 (53.1%)
Pleural effusion 7/64 (10.9%) 7/64 (10.9%)
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gists, making HRCT not only sensitive but also relatively 
objective.
We are aware that our sample is too small to make 
exhaustive judgements. Moreover, among the descrip-
tive limits of our experience it must be underlined that 
a mixed ground glass-consolidation pattern was record-
ed in the same way as a case where a ground glass area 
and a consolidation area were in 2 distinct lung areas. 
Furthermore, multiple and focal alterations, distributed 
peripherally and centrally, were recorded in the same 
way as a diffuse extension of disease (e.g. lobar). Finally, 
when present, atelectasis areas were recorded as consoli-
dations.
Conclusions
We report the data from our experience to show the 
most common pulmonary HRCT patterns of COVID-19 
presentation at an early stage. In addition, we would like to 
emphasize how the detection of such patterns can be per-
formed with excellent agreement by readers with different 
experience, and thus assign their exact diagnostic value in 
an appropriate clinical and environmental exposure setting. 
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